Interatrial Shunt Sensor Placement for Real-Time Pressure Regulation
Find Innovative SolutionsGenerate Solutions
Solution Overview
Problem
Current therapies for heart failure and pulmonary arterial hypertension, including implantable pressure sensors and interatrial shunts, face challenges such as delayed responses, potential over-treatment, and the need for caregiver intervention, while existing interatrial shunts may unmask underlying heart dysfunction.
Innovation Solution
An interatrial shunt device combined with an implantable physiologic sensor that measures physiologic parameters within the shunt, minimizing tissue overgrowth and providing real-time, automated pressure regulation without caregiver intervention.
Engineering Contradictions & Design Principles
Engineering Contradiction Analysis
1Speed
If implantable pressure sensors are used to monitor cardiovascular parameters, then real-time pressure regulation can be achieved, but delayed responses and potential over-treatment occur
Solution Approach 1:
The device incorporates a closed-loop feedback system where the physiologic sensor continuously monitors pressure parameters and automatically adjusts the shunt orifice area in real-time. This feedback mechanism eliminates delayed responses and prevents over-treatment by making adjustments only when and where physiologic conditions require them, thereby resolving the contradiction between speed and reliability.
Solution Approach 2:
The interatrial shunt device performs self-regulation through automated control algorithms that process sensor data and adjust the shunt opening without external intervention. This self-service capability ensures immediate response to pressure changes while maintaining treatment accuracy through embedded decision-making logic, resolving the contradiction between rapid response and reliable treatment.
2Ease of operation
If caregiver intervention is required for therapy adjustment, then treatment decisions can be made by medical professionals, but timely regulation is compromised
Solution Approach 1:
The device is designed to autonomously monitor physiologic parameters and adjust shunt opening without requiring caregiver intervention. The automated control system processes sensor data and implements therapy adjustments in real-time, eliminating delays associated with human response while maintaining medically sound decision-making through embedded algorithms.
Solution Approach 2:
The patent replaces the mechanical system of manual caregiver adjustment with an automated electronic control system that uses sensors, processors, and actuators. This substitution enables continuous real-time regulation without human intervention, resolving the contradiction between ease of operation and regulation timing.
3Stress or pressure
If interatrial shunts are used to regulate blood pressure, then pressure control can be achieved, but underlying heart dysfunction may be unmasked
Solution Approach 1:
The shunt device features a dynamic, adjustable orifice that can change its opening area in real-time based on physiologic conditions. Unlike fixed shunts that permanently alter hemodynamics, this dynamic system can modulate the shunt magnitude to maintain heart function stability while achieving blood pressure control, resolving the contradiction between pressure control and functional stability.
Solution Approach 2:
The device changes the shunt orifice area parameter dynamically in response to sensor feedback, allowing precise control of blood pressure while avoiding the fixed, potentially harmful hemodynamic alterations of traditional shunts. This parameter adjustment capability maintains heart function stability while achieving effective pressure regulation.
4Stress or pressure
If traditional interatrial shunts are used, then blood pressure regulation can be achieved, but tissue overgrowth occurs
Solution Approach 1:
The shunt device incorporates a thin-film or flexible membrane structure that minimizes tissue irritation and prevents excessive tissue overgrowth. This design maintains pressure regulation functionality while reducing the mechanical stimulus for fibrous tissue proliferation, resolving the contradiction between effective pressure control and minimal tissue response.
Data Source
AI summary
Interatrial shunts having incorporated physiologic sensors are provided for monitoring and treating cardiovascular syndromes, including heart failure and pulmonary hypertension, in which the one or more sensors are affixed to the shunt to measure a physiologic parameter within the interatrial shunt. The one or more sensors may be directly affixed to or within a lumenal surface of the shunt or may be disposed on a support structure in a spaced relation to the shunt lumen, the one or more sensors disposed at locations subject to little or no pannus formation or cardiac wall motion artifact.


